TC

23/06/2017 17:14

Shandong Xinhua (00719) sees interim profit to rise 100-150%

    Shandong Xinhua Pharmaceutical (00719) said it expects to record an increase of about 100%-150% in the net profit attributable to the shareholders for the period from 1 January 2017 to 30 June 2017 as compared to the corresponding period in 2016 to about Rmb92 million to Rmb114 million.
  During the reporting period, Shandong Xinhua had progressed in product techniques and reduced product costs and grasped the opportunity of the market, actively exploited the market, and expanded of sales volume.  

人氣文章
財經新聞
評論
專題
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

【嚴正聲明】《經濟通》呼籲公眾提高警覺留意偽冒《經濟通》投資群組

如何分辨問米是否真實?通靈問事用什麼工具都可以?靈靈法即場示範通靈!

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

大國博弈

貨幣攻略

說說心理話

Watche Trends 2024

北上食買玩

Art Month 2024

理財秘笈

夏天養生食療

消委會報告

山今養生智慧

輕鬆護老